3,3-disubstituted indolines

Details 3,3-disubstituted indolines 3,3-disubstituted indolines

1987-12-07

1989-10-24

Ford, John M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514253, 514252, 514269, 514272, 514274, 514275, 544295, 544316, 544317, 544296, 544319, 544333, 544334, 544335, 544238, 544320, 544321, 544328, 544329, 544331, 544332, 544336, 544405, 544408, 544409, 544410, 544327, A61K 3150, A61K 31505, C07D40306, C07D40314

Patent

active

048762598

ABSTRACT:
Cognitive deficiencies and/or neurological function deficits and/or mood and/or mental disturbances are treated by the administration of 3,3-disubstituted indolines. The indolines have the formula: ##STR1## wherein: p is 0 or 1;

REFERENCES:
patent: 3574232 (1971-04-01), Canas-Rodriguez et al.
patent: 4273860 (1981-06-01), Adin
patent: 4372960 (1983-02-01), L'Italien
patent: 4434169 (1984-02-01), Poschel et al.
patent: 4452990 (1984-06-01), Butler
Adir et al, Research Disclosures, 184, 446-454 (1979).
Daisley et al, J. Heterocyclic Chem., 19, 1013-1016 (1982).
Ogata et al, Eur. J. Med. Chem.--Chem. Ther. 16(4), 373-378 (1981).

Affiliated with

Also associated with

Rating

3,3-disubstituted indolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,3-disubstituted indolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,3-disubstituted indolines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1589427